laptm5

laptm5

Introduction

Laptm5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@autophagy2021]
title: LAPTM5 [@laptmmediated2022]
--- [@lysosomal2019]

<div class="infobox infobox-gene"> [@targeting2023]
<table> [@laptm2021]
<tr><th colspan="2" style="background:#f8f9fa; text-align:center;">LAPTM5 - Lysosomal associated transmembrane protein 5</th></tr> [@microglial2022]
<tr><td><b>Gene Symbol</b></td><td>LAPTM5</td></tr> [@lysosomal2023]
<tr><td><b>Full Name</b></td><td>Lysosomal associated transmembrane protein 5</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>1p35.1</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[57143](https://www.ncbi.nlm.nih.gov/gene/57143)</td></tr>
<tr><td><b>OMIM</b></td><td>[605365](https://www.omim.org/entry/605365)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000125351](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000125351)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9Y5W7](https://www.uniprot.org/uniprot/Q9Y5W7)</td></tr>
<tr><td><b>Associated Diseases</b></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis), Hematological malignancies</td></tr>
<tr><td><b>Protein</b></td><td>[LAPTM5 Protein](/proteins/laptm5-protein)</td></tr>
</table>
</div>

Overview

laptm5

Introduction

Laptm5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@autophagy2021]
title: LAPTM5 [@laptmmediated2022]
--- [@lysosomal2019]

<div class="infobox infobox-gene"> [@targeting2023]
<table> [@laptm2021]
<tr><th colspan="2" style="background:#f8f9fa; text-align:center;">LAPTM5 - Lysosomal associated transmembrane protein 5</th></tr> [@microglial2022]
<tr><td><b>Gene Symbol</b></td><td>LAPTM5</td></tr> [@lysosomal2023]
<tr><td><b>Full Name</b></td><td>Lysosomal associated transmembrane protein 5</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>1p35.1</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[57143](https://www.ncbi.nlm.nih.gov/gene/57143)</td></tr>
<tr><td><b>OMIM</b></td><td>[605365](https://www.omim.org/entry/605365)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000125351](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000125351)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9Y5W7](https://www.uniprot.org/uniprot/Q9Y5W7)</td></tr>
<tr><td><b>Associated Diseases</b></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis), Hematological malignancies</td></tr>
<tr><td><b>Protein</b></td><td>[LAPTM5 Protein](/proteins/laptm5-protein)</td></tr>
</table>
</div>

Overview

The LAPTM5 (Lysosomal Associated Transmembrane Protein 5) gene encodes a multi-pass membrane protein primarily localized to lysosomes and the endoplasmic reticulum. LAPTM5 is a member of the LAPTM family of proteins that play critical roles in lysosomal function, [autophagy](/entities/autophagy) regulation, and cellular homeostasis. The gene is expressed at high levels in immune cells and various brain regions, where it supports lysosomal trafficking, autophagy, and neuronal survival.

Gene Structure

The LAPTM5 gene spans approximately 12 kb on chromosome 1p35.1 and consists of multiple exons. The gene encodes a protein of approximately 397 amino acids with multiple transmembrane domains. Key features include:

• N-terminal cytoplasmic domain: Contains sorting motifs (YXXΦ) for lysosomal targeting
• Transmembrane regions: Four predicted transmembrane helices
• C-terminal cytoplasmic tail: Contains regulatory motifs for protein interactions

Normal Function

Lysosomal Trafficking and Biogenesis

LAPTM5 is essential for proper lysosomal trafficking and function. The protein interacts with components of the lysosomal trafficking machinery, including:

• V-ATPase: Maintains lysosomal acidification necessary for enzymatic activity[@laptm2020]
• Lysosomal-associated membrane proteins (LAMPs): Coordinates with other LAMP family members for lysosomal stability
• Vesicular traffic proteins: Facilitates transport of cargo between intracellular compartments

Autophagy Regulation

LAPTM5 plays a crucial role in the autophagy-lysosome pathway:

• Autophagosome-lysosome fusion: The protein promotes membrane fusion events necessary for autophagic degradation
• Lysosomal biogenesis: Coordinates with transcription factor [TFEB](/entities/tfeb) to maintain lysosomal population
• Selective autophagy: Facilitates clearance of protein aggregates and damaged organelles

Immune Cell Function

In hematopoietic cells, LAPTM5 expression is particularly high and regulates:

• B cell development: Essential for B cell receptor signaling and plasma cell differentiation
• T cell activation: Modulates T cell receptor signaling and cytokine production
• Myeloid cell function: Regulates macrophage and dendritic cell lysosomal function

Neuronal Function

In the central nervous system, LAPTM5 supports:

• Synaptic vesicle trafficking: Participates in synaptic vesicle recycling at presynaptic terminals
• Protein quality control: Enhances clearance of misfolded proteins through autophagy
• Lysosomal calcium regulation: Maintains lysosomal calcium stores important for signaling

Expression Pattern

LAPTM5 shows tissue-specific expression:

• High expression: Bone marrow, spleen, thymus (hematopoietic tissues)
• Moderate expression: Brain ([cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia), lung, kidney
• Cell type-specific: High in [microglia](/cell-types/microglia-neuroinflammation), [astrocytes](/entities/astrocytes), and certain neuronal populations

Role in Neurodegeneration

Alzheimer's Disease

LAPTM5 dysregulation contributes to Alzheimer's disease pathogenesis:

Parkinson's Disease

In Parkinson's disease, LAPTM5 has protective functions:

Amyotrophic Lateral Sclerosis

LAPTM5 is implicated in ALS through:

Therapeutic Implications

LAPTM5 represents a promising therapeutic target:

• Gene therapy: Viral vector-mediated LAPTM5 overexpression to enhance autophagy
• Small molecule activators: Compounds that upregulate LAPTM5 expression or function
• Combination approaches: Targeting LAPTM5 alongside other autophagy proteins
• Biomarker potential: LAPTM5 expression as a biomarker for lysosomal dysfunction

See Also

• [LAPTM5 Protein](/proteins/laptm5-protein)
• [Lysosomal Degradation](/mechanisms/lysosomal-degradation)
• [Autophagy Pathway](/mechanisms/autophagy)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Microglia](/cell-types/microglia)

Background

The study of Laptm5 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References